Journey Medical Corp (DERM)
3.93
+0.13
(+3.42%)
USD |
NASDAQ |
May 31, 16:00
3.93
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Cash and Short Term Investments (Quarterly): 24.06M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 24.06M |
| December 31, 2023 | 27.44M |
| September 30, 2023 | 24.75M |
| June 30, 2023 | 8.23M |
| March 31, 2023 | 17.35M |
| December 31, 2022 | 32.00M |
| September 30, 2022 | 34.89M |
| Date | Value |
|---|---|
| June 30, 2022 | 38.14M |
| March 31, 2022 | 41.33M |
| December 31, 2021 | 49.08M |
| September 30, 2021 | 21.69M |
| June 30, 2021 | 12.18M |
| December 31, 2020 | 8.246M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
8.23M
Minimum
Jun 2023
49.08M
Maximum
Dec 2021
26.11M
Average
24.75M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Fortress Biotech Inc | 83.77M |
| Stereotaxis Inc | 17.63M |
| GT Biopharma Inc | 9.807M |
| Cara Therapeutics Inc | 69.77M |
| FibroGen Inc | 177.60M |